Articares announces China’s NMPA has approved the H-Man for upper limb neurorehabilitation training
Posted By Articares |
Posted March 23, 2022
Articares, an international medtech company of intelligent robotic rehabilitation solutions for ageing population and for those suffering from sensorimotor control deficits, today announces that the H-Man has received approval from the China National Medical Products Administration (NMPA) for upper limb neurorehabilitation training.
“With China’s NMPA approval for the H-Man, our AI enabled upper limb training robot platform, we are proud to be able to offer physicians, clinicians, therapists and patients with sensorimotor control deficits an advanced robotic solution that adapts to the training needs of patients”, said Asif Hussain Ph.D, CEO of Articares.
“The H-Man, together with our Care Platform software is designed and developed from strong collaboration between physicians, clinicians, patients and Biomedical research scientists from internationally reputable healthcare organisations and research institutes. Our solutions are focused on helping patients to get back their Activities of Daily Living (ADL) through regular and intense rehabilitation training.”